horsechoker
The Caf's Ezza.
Wouldn't want to be the guy who messed up
Jaysus. They’re even doing a study in 6 months old upwards. The risk-benefit for young kids is such that you’d surely want an absolute shit load of long term safety data before dosing them. I’’ve never thought twice about giving my kids the usual vaccines but giving them one for a disease which will almost certainly do them no harm is a much bigger ask.
On the kids issue, and the does vaccination reduce infection as well as disease question, a bit of (good) news from Israel.
The preprint (beyond the summary and the graphs) is definitely for the statistically enthusiastic, the rest of us should read Hilda's tweets on it instead
My only question would be "Are the risks associated with the Astrazeneca vaccine greater than the risks from contracting Covid?"
If the answer is a negative then carry on and get vaccinated.
Is there any correlation with those who have suffered the reaction being the same as those who are at most risk of contracting Covid i.e immuno suppressed, respiratory illnesses etc?
The Oxford/AstraZeneca group have updated their UK trials data. They now have more cases (because the trial period was that much longer), and they've been able to split out data for those with the UK variant versus those with the original one.
The good news is that the efficacy looks good - probably benefiting from the longer time period from vaccination to infection. The quoted efficacy (all symptom severity) now looks like 70% against the UK variant, 81% against the original strain. Which is not a surprise since we're also seeing high levels of protection in the analysis coming from the UK rollout.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00628-0/fulltext
I've been told 2 weeks until you are considered protected.Do we have a feel from previous vaccines, how long we might expect the Ox/AZ and J&J vaxs to take to reach maximum protection? I've seen a few people suggest that it builds up over a longer time (so, for example, the South African trial might not be as bad as it appeared) but don't really know how much to take from that.
Seems to be a bit of radio silence on the clotting issue from U.K.The Oxford/AstraZeneca group have updated their UK trials data. They now have more cases (because the trial period was that much longer), and they've been able to split out data for those with the UK variant versus those with the original one.
The good news is that the efficacy looks good - probably benefiting from the longer time period from vaccination to infection. The quoted efficacy (all symptom severity) now looks like 70% against the UK variant, 81% against the original strain. Which is not a surprise since we're also seeing high levels of protection in the analysis coming from the UK rollout.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00628-0/fulltext
The Oxford/AstraZeneca group have updated their UK trials data. They now have more cases (because the trial period was that much longer), and they've been able to split out data for those with the UK variant versus those with the original one.
The good news is that the efficacy looks good - probably benefiting from the longer time period from vaccination to infection. The quoted efficacy (all symptom severity) now looks like 70% against the UK variant, 81% against the original strain. Which is not a surprise since we're also seeing high levels of protection in the analysis coming from the UK rollout.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00628-0/fulltext
Not really. The MHRA initial review has identified 5 cases of CSVT that may be related (by timing) to the vaccine in men under the age of 60. Which doesn't seem to fit the pattern observed in Germany/Norway where the main clusters have been seen in women.Seems to be a bit of radio silence on the clotting issue from U.K.
Pfizer has announced it's vaccine remains 91% effective after 6 months. Excellent news for the concerns about protection dropping off after a few months.
Still be a huge job every yearFantastic. Getting closer and closer to an annual booster being all that’s required.
Still be a huge job every year
Yeah but nearly 5m in a short space of time no?Not all that much work in addition to what we already do with annual flu jab (1 million people got flu vaccine in Ireland last year)
Yeah but nearly 5m in a short space of time no?
So far I've only been a bit sore on my arm and jaded. Nothing I couldn't be anyway from my normal life.
Oh, and body akes like hell, but that's been around for years.
Still be a huge job every year
Sleeping on it.What are doing in normal life that makes your arm sore. Oh wait a moment...
BBC News - Covid: Europe's vaccine rollout 'unacceptably slow' - WHO
https://www.bbc.co.uk/news/world-europe-56600660
I really hope things can start picking up in Europe in coming months. With the positive news about the vaccines if we can get acceptable numbers of people protected we can start to slowly see some normality again.
Sleeping on it.
Here I was thinking the point of sleeping on it being that It didn't feel as usual.Ahh the old stranger.....
In ireland we were meant to get 1m, it’s already down to just over 800k. This company is a disgraceI don't think anybody listens much to the WHO anymore. They're quickly dismissed by pretty much everybody in Italy after their handling of the pandemic.
There are few surprises in Europe despite certain news stories. We were about 15% down on expected deliveries during Q1. During Q2 we are expecting 400m doses to arrive, a 4x increase and almost enough for everybody on the continent. It's then up to individual countries to get them into arms.
The study said nine people in South Africa went down with Covid-19, all of whom were in the placebo group. None who had taken the companies’ vaccine were infected. Lab analysis of nine of the infections showed that six of the nine were from the B.1.351 strain.
We getting something like 10m-20m doses of Pfizer in Q3, so we’ll know for sure soon enough.Good news re Pfizer vaccine and SA variant. Small numbers (so statistical significance dubious) but still...
I had my first jab yesterday. It's the Sinovac one, which along with AZ is the only ones available right now here in Indonesia, but better than nothing and beyond elated nonetheless. No side effects throbbing pain on injection site aside. Have you had yours, @Sky1981?
My only question would be "Are the risks associated with the Astrazeneca vaccine greater than the risks from contracting Covid?"
If the answer is a negative then carry on and get vaccinated.
Is there any correlation with those who have suffered the reaction being the same as those who are at most risk of contracting Covid i.e immuno suppressed, respiratory illnesses etc?